Sight Sciences study demonstrates benefits of OMNI system for managing POAG
Sight Sciences (SGHT) announced the publication of a landmark 36-month analysis evaluating the long-term effectiveness of the OMNI Surgical ...
ophthalmologytimes2h
Acelyrin unveils phase 3 program design for lonigutamab in thyroid eye disease
The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.
ophthalmologyadvisor19h
In-Office Suprachoroidal Viscopexy Shows Promise As Retinal Detachment Treatment
In-office suprachoroidal viscopexy may be a feasible approach for repairing rhegmatogenous retinal detachment.
Endovascular Today14h
Stent Graft Use in Cephalic Vein Arch Stenosis: Why, When, and How?
Venoplasty alone for CAS does not provide a durable solution due to the frequent reinterventions that are required. Bare-metal stent (BMS) placement has been described with variable results. In their ...